{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:40:14Z","timestamp":1790822414225,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T00:00:00Z","timestamp":1531785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.vaccine.2018.07.023","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T01:08:20Z","timestamp":1532480900000},"page":"176-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study"],"prefix":"10.1016","volume":"37","author":[{"given":"Alfonso","family":"Carmona Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Prymula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Miranda Valdivieso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Carmen","family":"Otero Reigada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Manuel","family":"Merino Arribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Brzostek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Szenborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Ruzkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Jackowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Centeno-Malfaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Traskine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Dobbelaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Borys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.07.023_b0005","first-page":"129","article-title":"Pneumococcal vaccines WHO position paper \u2013 2012","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2018.07.023_b0010","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/erv.09.113","article-title":"10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: synflorix","volume":"8","author":"Prymula","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.07.023_b0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40272-013-0047-z","article-title":"13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents","volume":"15","author":"Plosker","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.vaccine.2018.07.023_b0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-2600(14)70060-8","article-title":"Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study","volume":"2","author":"Domingues","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2018.07.023_b0025","unstructured":"International Vaccine Access Center (IVAC), Johns Hopkins Bloomberg School of Public Health. Pneumococcal conjugate vaccine (PCV) product assessment; April 2017. Available at <http:\/\/www.jhsph.edu\/research\/centers-and-institutes\/ivac\/resources\/pcv-product-assessment-april-25-2017.pdf> [accessed 7 March 2018]."},{"key":"10.1016\/j.vaccine.2018.07.023_b0030","doi-asserted-by":"crossref","first-page":"e0166736","DOI":"10.1371\/journal.pone.0166736","article-title":"Impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American countries: a systematic review","volume":"11","author":"de Oliveira","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.07.023_b0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12879-015-1147-x","article-title":"Pneumococcal serotype evolution in Western Europe","volume":"15","author":"Tin Tin Htar","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.023_b0040","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.vaccine.2015.04.025","article-title":"Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults","volume":"33","author":"McFetridge","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.023_b0045","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.023_b0050","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2018.07.023_b0055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CVI.00289-09","article-title":"Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines","volume":"17","author":"Poolman","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.07.023_b0060","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.vaccine.2006.09.029","article-title":"Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children","volume":"25","author":"Henckaerts","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.023_b0065","unstructured":"World Health Organization, Expert Committee on Biological Standardization. Recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines. Geneva, 19\u201323 October 2009. Available at <http:\/\/www.who.int\/biologicals\/areas\/vaccines\/pneumo\/Pneumo_final_23APRIL_2010.pdf?ua=1> [accessed 7 May 2018]."},{"key":"10.1016\/j.vaccine.2018.07.023_b0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/CVI.00344-08","article-title":"Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A","volume":"16","author":"Lee","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.07.023_b0075","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/INF.0b013e318199f609","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different Neisseria meningitidis serogroup C conjugate vaccines","volume":"28","author":"Wysocki","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.07.023_b0080","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.07.023_b0085","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.vaccine.2016.03.107","article-title":"Status of research and development of pediatric vaccines for Streptococcus pneumoniae","volume":"34","author":"Alderson","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.023_b0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1586\/erv.12.5","article-title":"Issues and challenges in the development of pneumococcal protein vaccines","volume":"11","author":"Ginsburg","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.07.023_b0095","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.vaccine.2017.03.071","article-title":"Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: a phase 2, randomized, controlled, observer-blind study","volume":"35","author":"Odutola","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.023_b0100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/21645515.2015.1111496","article-title":"Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2\u20134 years: a phase II randomized study","volume":"12","author":"Odutola","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.07.023_b0105","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/j.vaccine.2014.03.066","article-title":"Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial","volume":"32","author":"Prymula","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.023_b0110","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1016\/j.vaccine.2017.07.008","article-title":"Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: results from a randomized phase II study in infants","volume":"35","author":"Prymula","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.023_b0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12916-016-0755-7","article-title":"Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis","volume":"14","author":"Alari","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2018.07.023_b0120","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1016\/j.vaccine.2016.05.047","article-title":"Pneumococcal carriage in young children after introduction of PCV13 in Hong Kong","volume":"34","author":"Chan","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.023_b0125","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/INF.0000000000001206","article-title":"Emerging Streptococcus pneumoniae strains colonizing the nasopharynx in children after 13-valent pneumococcal conjugate vaccination in comparison to the 7-valent era, 2006\u20132015","volume":"35","author":"Kaur","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.07.023_b0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nmni.2015.11.001","article-title":"Emerging non-PCV13 serotypes of noninvasive Streptococcus pneumoniae with macrolide resistance genes in northern Japan","volume":"9","author":"Kawaguchiya","year":"2015","journal-title":"New Microbes New Infect"},{"key":"10.1016\/j.vaccine.2018.07.023_b0135","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1016\/j.vaccine.2016.07.031","article-title":"Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8 years after vaccine introduction in Stockholm, Sweden","volume":"34","author":"Lindstrand","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.023_b0140","doi-asserted-by":"crossref","first-page":"E265","DOI":"10.33321\/cdi.2015.39.23","article-title":"Invasive pneumococcal disease in Australia, 2009 and 2010","volume":"39","author":"Bareja","year":"2015","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.vaccine.2018.07.023_b0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12890-016-0242-0","article-title":"A systematic review of the burden of vaccine preventable pneumococcal disease in UK adults","volume":"16","author":"Chalmers","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.vaccine.2018.07.023_b0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12879-015-0787-1","article-title":"Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany","volume":"15","author":"Imohl","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.023_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2018.07.023_b0160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1469-0691.2009.02726.x","article-title":"Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae","volume":"15","author":"Dagan","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2018.07.023_b0165","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/21645515.2015.1118593","article-title":"Interim results of an ecological experiment - conjugate vaccination against the pneumococcus and serotype replacement","volume":"12","author":"Hausdorff","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2018.07.023_b0170","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)","volume":"28","author":"Knuf","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.07.023_b0175","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1097\/INF.0000000000001170","article-title":"Immunogenicity, safety and reactogenicity of a booster dose of the 10-valent pneumococcal nontypeable H. influenzae protein D conjugate vaccine coadministered with DTPa-IPV-Hib in Dutch children: a randomized controlled trial","volume":"35","author":"van den Bergh","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.07.023_b0180","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.vaccine.2013.11.028","article-title":"Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada","volume":"32","author":"De Wals","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.023_b0185","doi-asserted-by":"crossref","first-page":"e0120290","DOI":"10.1371\/journal.pone.0120290","article-title":"Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children-a population-based study","volume":"10","author":"Jokinen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.07.023_b0190","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/INF.0b013e318199f62d","article-title":"Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines","volume":"28","author":"Chevallier","year":"2009","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18309897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18309897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:31:37Z","timestamp":1751761897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18309897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0264410X18309897"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}